02-Jun-2025Today's Market Indicators

Torrent Pharmaceuticals Ltd

  • Industry: Pharmaceuticals Indian Formulations
  • Market Cap (₹ Cr.): 107416.07
  • CURRENT PRICE (₹)
      3,130.90  -43.05(-1.36 %)
    02-Jun-2025 12:00:00 AM
    Volume 5,813
  • Day's Open (₹)
    3,164.50
  • Day's High (₹)
    3,164.50
  • Day's Low (₹)
    3,103.00
  • Prev.Close (₹)
    3,173.95
JavaScript chart by amCharts 3.21.1409:0109:2909:5310:1710:4111:0511:2911:5312:1712:4101:0501:2901:5302:1702:4103:0503:293,0503,1003,1503,2003,250

52 Week High/Low 3,589.95 / 2,576.40

0.03%

Stock Trivia

30-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Copy
23-May-25
Torrent Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)
21-May-25
Stock Alert: Dixon Tech, Torrent Pharma, United Spirits, Aster DM Hea
21-May-25
Torrent Pharmaceuticals consolidated net profit rises 10.91% in the M
21-May-25
Torrent Pharma gains as Q4 PAT rises 11% YoY to Rs 498 cr; recommends
21-May-25
Torrent Pharmaceuticals Ltd - Compliances-Reg.24(A)-Annual Secretaria
21-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Updat
20-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Updat
20-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Inves
20-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Divid
20-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Outco
20-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Press
20-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Outco
12-May-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Chang
28-Mar-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Tradi
28-Mar-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Tradi
27-Mar-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Issue
26-Mar-25
Torrent Pharmaceuticals Ltd - Redemption Of Commercial Paper Issued U
26-Mar-25
Torrent Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)
26-Mar-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Issue
20-Mar-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Credi
19-Mar-25
Torrent Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)
28-Feb-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Resig
27-Feb-25
Torrent Pharmaceuticals announces resignation of ED (Strategic Planni
21-Feb-25
Torrent Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)
21-Feb-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Analy
17-Feb-25
Torrent Pharmaceuticals Ltd - Disclosure Under Regulation 30 Of SEBI
17-Feb-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Analy
14-Feb-25
Torrent Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)
14-Feb-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Analy
10-Feb-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Analy
31-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Analy
27-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Press
24-Jan-25
Torrent Pharmaceuticals consolidated net profit rises 13.54% in the D
24-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Divid
24-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Finan
24-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Inves
15-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Analy
14-Jan-25
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Board
27-Dec-24
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Issue
09-Dec-24
Torrent Pharmaceuticals Ltd - Torrent Pharmaceuticals Limited - Copy
05-Dec-24
Torrent Pharma to acquire three anti-diabetes brands from Boehringer

Score Board

Mar 25
(Latest Qtr)
FY24
(Latest Financial Year)
Market Cap (₹ Cr)109468.6588030.78
Sales(₹ Cr)2385.008532.90
(% Change)2%11%
Net Profit(₹ Cr)474.001357.08
(% Change)-2%29%
Per Share Data
Earnings (₹)14.0040.10
Book Value (₹)0.00201.76
Cash (₹)110.0085.48
Dividend (₹)0.0028.00

Key Ratios

Important Finanical ratios for

FY24FY23FY22FY21FY20
EPS40.1031.0658.5867.2355.45
Book Value per share201.76190.75374.94356.30302.59
Dividend per share28.0022.0048.0035.0032.00

Financial Health

Profit & Loss

Mar 2025Dec 2024Sep 2024Jun 2024
Gross Sales 2385.002330.002376.002394.00
Other Operating Income 48.0047.0058.0044.00
Other Income  15.003.00-7.0021.00
Total Income 2448.002380.002427.002459.00
Total Expenditure  1589.001490.001513.001539.00
PBIDT 859.00890.00914.00920.00
Interest  47.0048.0054.0064.00
PBDT 812.00842.00860.00856.00
Depreciation 190.00191.00190.00189.00
Tax 160.00125.00139.00117.00
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -12.0041.0071.0081.00
Reported Profit After Tax 474.00485.00460.00469.00
Extra-ordinary Items  -17.830.000.000.00
Adjusted Profit After Extra-ordinary item 491.83485.00460.00469.00
     
EPS (Unit Curr.) 14.0014.3313.6013.86
EPS (Adj) (Unit Curr.) 14.0014.3313.6013.86
Calculated EPS (Unit Curr.) 14.0014.3313.5913.86
Calculated EPS (Adj) (Unit Curr.) 14.0014.3313.5913.86
Calculated EPS (Ann.) (Unit Curr.) 56.0257.3254.3655.43
Calculated EPS (Adj) (Ann.) (Unit Curr.) 56.0257.3254.3655.43
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.00520.000.000.00
Equity 169.23169.23169.23169.23
Reserve & Surplus 0.000.000.000.00
Face Value 5.005.005.005.00
     
Public Shareholding (No. Of Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 36.0238.2038.4738.43
PBDTM(%) 34.0536.1436.2035.76
PATM(%) 19.8720.8219.3619.59
Dividend Per Share(Rs) 0.0026.000.000.00
Diluted EPS 14.0014.3313.6013.86

Balance Sheet

FY24FY23FY22FY21FY20
SOURCES OF FUNDS :     
Share Capital 169.23169.2384.6284.6284.62
Reserves Total 6659.536286.736260.805945.485036.35
Equity Share Warrants0.000.000.000.000.00
Equity Application Money0.000.000.000.000.00
Total Shareholders Funds6828.766455.966345.426030.105120.97
Secured Loans 2982.964365.563143.414184.784991.22
Unsecured Loans 361.24209.91204.10219.36303.12
Total Debt3344.204575.473347.514404.145294.34
Other Liabilities292.35266.87217.83200.49251.57
Total Liabilities10465.3111298.309910.7610634.7310666.88
APPLICATION OF FUNDS :     
Gross Block 12999.8112366.8610002.359952.749805.61
Less : Accumulated Depreciation 5013.894395.013751.103211.502608.11
Less:Impairment of Assets0.000.000.000.000.00
Net Block 7985.927971.856251.256741.247197.50
Lease Adjustment0.000.000.000.000.00
Capital Work in Progress226.23697.93567.50588.11536.41
Producing Properties0.000.000.000.000.00
Investments 463.31361.21367.64313.92134.89
Current Assets, Loans & Advances     
Inventories 1565.591602.231797.111911.741507.76
Sundry Debtors 1571.941729.441541.351544.261508.94
Cash and Bank Balance108.76147.6169.4666.42390.95
Loans and Advances 353.73291.71468.15480.41411.59
Total Current Assets3600.023770.993876.074002.833819.24
Less : Current Liabilities and Provisions     
Current Liabilities 1054.531021.70927.901019.481123.82
Provisions 200.94150.63120.34106.8393.77
Total Current Liabilities & Provisions1255.471172.331048.241126.311217.59
Net Current Assets2344.552598.662827.832876.522601.65
Miscellaneous Expenses not written off 0.000.000.000.000.00
Deferred Tax Assets405.38612.85796.861026.911003.33
Deferred Tax Liability1061.191014.15990.42998.58935.57
Net Deferred Tax-655.81-401.30-193.5628.3367.76
Other Assets101.1169.9590.1086.61128.67
Total Assets10465.3111298.309910.7610634.7310666.88
Contingent Liabilities1036.071017.36928.05126.18132.56

Cash Flow

FY24FY23FY22FY21FY20
Net Cash from Operating Activities2893.12265.412140.11572.891579.9
Net Cash Used In Investing Activities-296.07-2325.75-159.7-316.28269.43
Net Cash Used In Financing Activities-2577.5780.74-1977.27-1581.2-1555.48
Net Inc/Dec In Cash And Cash Equivalents19.4620.43.13-324.59293.85
Cash And Cash Equivalents At End Of The Year104.8685.46561.87386.46

Peer Comparison

Performance of Torrent Pharmaceuticals Ltd Compared to its peers in Pharmaceuticals Indian Formulations

Company Market Cap   help

Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.

(₹ in Cr.)
P/E  help

The price-to-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings (EPS).

(X)
P/B  help

The PBV ratio is the market price per share divided by the book value per share. For example, a stock with a PBV ratio of 2 means that we pay Rs 2 for every Rs. 1 of book value. The higher the PBV, the more expensive the stock. Most companies have a PBV greater than one.

(X)
EV/EBITDA  help

Enterprise value/EBITDA is a popular valuation multiple used in the finance industry to measure the value of a company. It is the most widely used valuation multiple based on enterprise value and is often used in conjunction with, or as an alternative to, the P/E ratio to determine the fair market value of a company.

ROCE  help

Return on capital employed is an accounting ratio used in finance, valuation, and accounting. It is a useful measure for comparing the relative profitability of companies after taking into account the amount of capital used.

( % )
Dividend  help

A dividend is a payment made by a corporation to its shareholders, usually as a distribution of profits. When a corporation earns a profit or surplus, the corporation is able to re-invest the profit in the business and pay a proportion of the profit as a dividend to shareholders.

( % )
Debit to Equity  help

The debt-to-equity ratio is a financial ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. Closely related to leveraging, the ratio is also known as risk, gearing or leverage.

(Ratio(D / E) )
Torrent Pharmaceuticals Ltd10595955.6112.8930.6920.401.020.60
Sun Pharmaceutical Industries Ltd40186593.8316.4157.6312.220.960.40
Divis Laboratories Ltd17357478.586.7551.5916.270.460.00
Cipla Ltd11870324.104.3116.7520.101.090.00
Dr Reddys Laboratories Ltd10423219.484.2212.7525.400.640.02